|
CSDE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.208700386092E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.77009995550037E-09 |
| Normal-vs-Stage2 |
2.06349999999356E-05 |
| Normal-vs-Stage3 |
1.8112999988773E-08 |
| Normal-vs-Stage4 |
8.25239999668881E-08 |
| Stage1-vs-Stage2 |
9.996600E-01 |
| Stage1-vs-Stage3 |
4.590400E-01 |
| Stage1-vs-Stage4 |
3.555800E-01 |
| Stage2-vs-Stage3 |
6.294000E-01 |
| Stage2-vs-Stage4 |
4.691400E-01 |
| Stage3-vs-Stage4 |
7.546600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.08959952171972E-10 |
| Normal-vs-AfricanAmerican |
4.104000E-02 |
| Normal-vs-Asian |
3.64369999950043E-07 |
| Caucasian-vs-AfricanAmerican |
3.386000E-02 |
| Caucasian-vs-Asian |
7.403200E-01 |
| AfricanAmerican-vs-Asian |
3.496300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.76170003427256E-09 |
| Normal-vs-Female |
4.6787995700015E-10 |
| Male-vs-Female |
5.000600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.00899999863924E-08 |
| Normal-vs-Age(41-60Yrs) |
5.61960034062281E-10 |
| Normal-vs-Age(61-80Yrs) |
9.66890000286824E-08 |
| Normal-vs-Age(81-100Yrs) |
9.238700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.423200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.232200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.843200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.799000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.273000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.890400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.272400E-01 |
| Classical-VS-Follicular |
2.038600E-01 |
| Classical-VS-Other |
3.276600E-01 |
| Classical-VS-Normal |
3.31719995916302E-09 |
| Tall-VS-Follicular |
8.440400E-01 |
| Tall-VS-Other |
7.266800E-01 |
| Tall-VS-Normal |
3.41930000002932E-06 |
| Follicular-VS-Other |
7.111200E-01 |
| Follicular-VS-Normal |
3.7830999999322E-07 |
| Other-VS-Normal |
5.876000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.22170007022771E-10 |
| Normal-vs-N1 |
8.97339980099332E-10 |
| N0-vs-N1 |
4.876100E-02 |
|
|
